Key Trends and Insights into the Pericarditis Market: Growth Rate and Opportunities to 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the pericarditis market?
There has been a substantial growth in the size of the pericarditis market in the previous years. The market is projected to expand from a value of $2.32 billion in 2024 to $2.51 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.2%. Factors such as a rise in cardiovascular disease cases, an aging population prone to higher disease risks, enhanced knowledge about disease pathophysiology, worldwide healthcare expansion, and progress in drug development and innovation have contributed to this growth witnessed in the historical period.
What will be the pericarditis market size in the future?
Strong expansion is expected in the pericarditis market size over the coming years, with forecasts suggesting it will reach $3.45 billion by 2029, achieving a compound annual growth rate (CAGR) of 8.2%. This predicted upswing during the forecast period is attributable to factors such as heightened emphasis on specialized treatment methods, regulatory backing for unique medicines, active patient advocacy and assistance groups, increasing investigation into inflammation processes, along with worldwide initiatives for preventing heart diseases. Noteworthy trends for the forthcoming period encompass advancements in techniques for diagnosis, the incorporation of AI in diagnostic processes, dealing with recurring pericarditis, the use of telemedicine in continuing patient care, patient training and support, as well as improvements in imaging technologies.
Get your pericarditis market report here!
https://www.thebusinessresearchcompany.com/report/pericarditis-global-market-report
What main drivers are fueling expansion in the pericarditis market?
The escalating occurrences of cardiovascular diseases are presumed to thrust the growth of the pericarditis market. These diseases, affecting the heart or blood vessels, are generally associated with a buildup of fatty substances within the arteries and a heightened risk of blood clots. Untreated pericarditis can contribute to multiple cardiovascular complications or even death in severe cases, thereby the increasing instances of cardiovascular diseases are pushing the market forward. As reported by the Centers for Disease Control and Prevention, a public health agency in the US, in October 2022, a heart attack happens in the United States every 40 seconds. Roughly 805,000 Americans are afflicted with a heart attack yearly. One in five heart attacks go unnoticed, with the victim oblivious to the harm inflicted. Major contributors to heart disease include smoking, high blood pressure, and elevated cholesterol. Consequently, the rising instances of cardiovascular diseases are fueling the expansion of the pericarditis devices market.
What key areas define the segmentation of the global pericarditis market?
The pericarditis market covered in this report is segmented –
1) By Type: Acute Pericarditis, Chronic Pericarditis, Recurrent Pericarditis
2) By Diagnosis And Treatment: Electrocardiogram (ECG), Echocardiogram, Computerized Tomography (Ct), X-Ray, Medication, Surgical Treatment
3) By Application: Hospitals And Clinics, Medical Institutes, Ambulatory Surgical Centers, Research Organizations
Subsegments:
1) By Acute Pericarditis: Viral Pericarditis, Bacterial Pericarditis, Idiopathic Pericarditis
2) By Chronic Pericarditis: Constrictive Pericarditis, Non-constrictive Chronic Pericarditis
3) By Recurrent Pericarditis: Post-Acute Pericarditis Recurrences, Secondary Recurrent Pericarditis
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9170&type=smp
Who are the dominant players expanding their reach in the pericarditis market?
Major companies operating in the pericarditis market include Pfizer Inc., AstraZeneca plc, Merck & Co. Inc., Novartis International AG, Johnson & Johnson Services Inc., Takeda Pharmaceutical Co. Ltd., Zydus Cadila Healthcare Ltd., Sun Pharmaceutical Ltd., Kiniksa Pharmaceuticals Ltd., R-Pharm International LLC, Regeneron Pharmaceuticals Inc., Amgen Inc., UCB S.A., Daiichi Sankyo Company, Limited, Astellas Pharma Inc., Biogen Inc., Gilead Sciences, Inc., Merck KGaA, Ipsen S.A., and Hikma Pharmaceuticals plc
How are evolving market trends shaping pericarditis Strategies?
Leading firms in the pericarditis market are introducing innovative solutions such as pericardial tissue valves to capture a larger market share, boost sales, and elevate revenue. Pericardial tissue valves are medical devices specifically designed for cardiac surgeries, especially those involving heart valve repair or replacement. For instance, in September 2022, the US-based tech firm, Edwards Lifesciences, debuted the SAPIEN 3 Ultra RESILIA valve. Highlighted by its distinctive features, the SAPIEN 3 Ultra RESILIA valve combines Edwards’ pioneering RESILIA tissue technology with the top-ranked SAPIEN 3 Ultra transcatheter aortic heart valve. Notably, the RESILIA tissue includes progressive anti-calcification technology, effectively tackling a key element causing the requirement for reintervention after heart valve replacement. The SAPIEN 3 Ultra RESILIA valve stands as a significant example of Edwards’ continued dedication to innovation, aiming to address the current and future needs of patients, ultimately improving their lifespan, health, and overall wellbeing.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9170
Which regions are emerging as leaders in the pericarditis market?
North America was the largest region in the pericarditis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the pericarditis market report during the forecast period. The regions covered in the pericarditis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Electronic Design Automation Software Global Market Report 2024
Ventricular Assist Device Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report
Power Generators Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/power-generators-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
